Amit Oza News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A closer look at why PARP inhibitor's third-line indication was withdrawn

72-acre site in Wiltshire marks first step in Centrica's push to deliver 650MW of solar capacity by 2026

Centrica is targeting 900MW of solar and battery storage capacity in the UK by 2026

email article Adding the Wee1 inhibitor adavosertib to gemcitabine reduced the risk of disease progression and death in women with recurrent, platinum-resistant or -refractory ovarian cancer, a randomized phase II trial showed. For the primary endpoint of progression-free survival (PFS) in 99 patients with high-grade serous tumors, those assigned to gemcitabine plus adavosertib had a median PFS of 4.6 months, as compared with 3.0 months with gemcitabine plus placebo (HR 0.55, 95% CI 0.35-0.90, P=0.015), reported Amit Oza, MD, of Princess Margaret Cancer Centre in Toronto, and colleague...

Anthem, so i think it's a little overblown. i don't know if they knew they were going to cause a controversy, but i guess they probably did. >> i looked at it oza compliment to the united states. people know we're the best country in the world, which is why they want to come here. i agree with eric. i get tired of having multiculturalism sold to me as soda pop. that bothers me. however, i can't get outraged and i think sometimes this can be used as an outrage trap, to get people angry. i just let it go. >> i'll tell you outrage. i'm embroiled in a very difficult love triangle. i have tossed an...